Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study

OBJECTIVES: We examined the association of plasminogen activator inhibitor-1 (PAI-1) levels with colorectal cancer, breast cancer, acute coronary syndrome (ACS) and ischaemic stroke. DESIGN: Nested case-cohort study. SETTING: The European Prospective Investigation into Cancer and Nutrition-Italy coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacoviello, Licia, Agnoli, Claudia, De Curtis, Amalia, di Castelnuovo, Augusto, Giurdanella, Maria Concetta, Krogh, Vittorio, Mattiello, Amalia, Matullo, Giuseppe, Sacerdote, Carlotta, Tumino, Rosario, Vineis, Paolo, de Gaetano, Giovanni, Panico, Salvatore, Donati, Maria Benedetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831102/
https://www.ncbi.nlm.nih.gov/pubmed/24231461
http://dx.doi.org/10.1136/bmjopen-2013-003725

Ejemplares similares

Ejemplares similares